PhRMA Comments on the Negotiating Objectives for a U.S.-Japan Trade Agreement
PhRMA’s submission to the Office of the U.S. Trade Representative on
the negotiating objectives for a U.S.-Japan Trade Agreement outlines
ways to eliminate Japanese barriers to trade that would foster even
greater exports to this important market for biopharmaceutical
innovators.